ADAR1 loss-of-function or mutation results in the accumulation of endogenous Z-RNA, relieving ZBP1 inhibition and strongly driving ZBP1-dependent PANoptosis, which is critical for tumor immune editing and treatment resistance (46). The gene discussed is ZBP1; the disease is neoplasm.